Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-21 Option Award |
2024-02-23 4:50 pm |
N/A 2034-02-21 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER |
140,000 | $0 | 140,000 (Direct) |
View |
| 2023-03-14 Option Award |
2023-03-16 4:28 pm |
N/A 2033-03-14 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Operating Officer |
275,000 | $0 | 275,000 (Direct) |
View |
| 2022-09-13 Option Award |
2022-09-15 4:45 pm |
N/A 2032-09-13 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence CHIEF OPERATING OFFICER |
274,875 | $0 | 274,875 (Direct) |
View |
| 2022-03-16 Option Award |
2022-03-18 9:15 pm |
N/A 2032-03-16 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer |
24,972 | $0 | 24,972 (Direct) |
View |
| 2021-10-22 Option Award(A) |
2021-11-24 7:37 pm |
N/A 2027-03-12 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer |
294,200 | $0 | 294,200 (Direct) |
View |
| 2021-10-22 Option Award |
2021-10-26 9:48 pm |
N/A 2027-03-27 |
SAB Biotherapeutics Inc. | SABS | Bausch Christoph Lawrence Chief Science Officer |
375,625 | $0 | 375,625 (Direct) |
View |